Business
Extension of Shard Facility Tranche 1
Extension of Shard Facility Tranche 1.
About this update from Zanaga Iron Ore Co. Ltd.
[{"type":"text","content":"\n \n \n \n RNS Number : 5108A\n Zanaga Iron Ore Company Ltd\n 30 September 2020\n \n \n \n \n 30 September 2020 \n \n \n \n \n \n Extension of Shard Facility Tranche 1\n \n \n \n \n \n Zanaga Iron Ore Company (\"ZIOC\" or the \"Company\") (AIM:ZIOC) announces that, further to the announcement dated 26 June 2020 in relation to the Subscription Agreement with Shard Capital, the permitted sale period for the first tranche of the Company's shares issued pursuant to the Subscription Agreement has been extended by three months, as provided for in the Subscription Agreement. As announced in the Company's half-year results on 29 September 2020, of the 7 million shares issued to Shard Capital under the first tranche of the Subscription Agreement approximately 5 million of the shares have been successfully placed by Shard Capital as at 28 September 2020. \n \n ______________________________________________\n \n \n \n The Zanaga Iron Ore Company Limited LEI number is 21380085XNXEX6NL6L23.\n \n \n \n \n Zanaga Iron Ore\n \n \n Corporate Development and Andrew Trahar\n \n \n Investor Relations Manager +44 20 7399 1105\n \n \n Liberum Capital Limited\n \n \n Nominated Adviser, Financial Scott Mathieson, Edward Thomas \n \n \n Adviser and Corporate Broker \n +44 20 3100 2000\n \n \n About us:\n \n Zanaga Iron Ore Company Limited (\"ZIOC\" or the \"Company\") (AIM ticker: ZIOC) is the owner of 50% less one share in the Zanaga Iron Ore Project based in the Republic of Congo (Congo Brazzaville) through its investment in its associate Jumelles Limited. The Zanaga Iron Ore Project is one of the largest iron ore deposits in Africa and has the potential to become a world-class iron ore producer.\n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as ...